Dear European Dermatology Forum,
We would be incredibly grateful if you could use your networks to raise awareness by emailing your members an update on the progress of the SECURE-AD registry: https://www.secure-derm.com/. Please find our draft email for this below.
To date we have collected data on 190 cases of confirmed or suspected COVID-19 in atopic dermatitis. We will include everyone who enters a case as a co-author under the SECURE-AD Study Group in resulting publications.
It would also be great if your organization could share this initiative via social media, tagging us @ad_secure (Twitter) and @secure.derm (Instagram). For your convenience, please find our logo’s attached.
Only with the collaboration of the international AD community, we will be able to investigate the impact of COVID-19 on our patients.
Thank you very much for your continued support.
Best wishes,
Profs Alan Irvine, Phyllis Spuls & Carsten Flohr
On behalf of the SECURE-AD Team
